CG
ALT icon

Cutler Group’s Altimmune ALT Stock Holding History

Cutler Group’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$6K Sell
2,100
-4,200
-67% -$42.7K ﹤0.01% 1469
2023
Q4 		$12K Buy
+6,300
New +$26.3K ﹤0.01% 2271
2023
Q2 		– Sell
-25,600
Closed -$2K – 3513
2023
Q1 		$2K Sell
25,600
-1,800
-7% -$21.4K ﹤0.01% 3066
2022
Q4 		$117K Buy
27,400
+16,400
+149% +$184K 0.01% 1073
2022
Q3 		$36K Buy
+11,000
New +$162K ﹤0.01% 2131
2021
Q4 		– Sell
-42,200
Closed -$9K – 5308
2021
Q3 		$9K Buy
42,200
+38,500
+1,041% +$468K ﹤0.01% 3982
2021
Q2 		$1K Buy
3,700
+1,200
+48% +$16.4K ﹤0.01% 5186
2021
Q1 		$9K Hold
2,500
– – ﹤0.01% 3860
2020
Q4 		$6K Buy
2,500
+1,300
+108% +$15.3K ﹤0.01% 3496
2020
Q3 		$1K Sell
1,200
-17,800
-94% -$356K ﹤0.01% 4222
2020
Q2 		$63K Buy
+19,000
New +$104K ﹤0.01% 1596

Other funds holding ALT

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Cutler Group's ALT Position: Q1 2024 in Review

Cutler Group reduced its Altimmune (ALT) stake by 77% in Q1 2024, selling an estimated $17.3K and leaving 500 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #1536.

Cutler Group first reported a position in ALT in Q1 2020 and has held it in 15 quarters since. The position peaked at $326K in Q3 2022. 172 funds tracked by Wall St. Rank hold ALT as of Q1 2024.

  • Cutler Group held 500 shares of Altimmune worth $5K as of Q1 2024.
  • Cutler Group sold 1,700 Altimmune shares in Q1 2024, an estimated $17.3K.
  • Altimmune made up ﹤0.01% of Cutler Group's portfolio in Q1 2024, its #1536 holding.
  • Cutler Group first reported a position in Altimmune in Q1 2020 and has held it in 15 quarters since.
  • Cutler Group's Altimmune position peaked at $326K in Q3 2022.
  • 172 funds tracked by Wall St. Rank held Altimmune as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.